Advances in R/R Multiple Myeloma: Practical Guidance for Newly Approved and Emerging Therapies

Download All
Gain expert pharmacist perspective on newly approved and emerging therapies for relapsed/refractory multiple myeloma with a webcast of a live webinar plus downloadable slidesets.
Sagar Lonial, MD
Kathryn Maples, PharmD, BCOP

On-Demand Webcast

In this on-demand webcast from a live symposium, pharmacy and oncology experts Kathryn Maples, PharmD, BCOP, and Sagar Lonial, MD, discuss best practices in using newer agents to improve outcomes in patients with relapsed/refractory multiple myeloma.

Sagar Lonial, MD Kathryn Maples, PharmD, BCOP Pharmacists: 1.0 contact hour (0.1 CEUs) Released: May 28, 2021 Expired: May 27, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie Inc.
Bristol-Myers Squibb
Karyopharm Therapeutics

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.